Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma
Clinical trial NCT02892019 · COMPLETED
Trial details
- NCT number
- NCT02892019
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-18
- Primary completion
- 2019-06-19
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.